Case Report of International Journal of Case Reports
Fibromyalgia as A Sole First Presentation of Recurring Idiopathic Intracranial Hypertension in a child. A Case Report and Literature Review
Sondos Altaraqji1, Rayan S. Terkawi2,3, Abdallah Alneirab2,3, Diyaa Rachdan4,5 and Khalid Mohamed1
1Pediatric Neurology Division, Sidra Medicine, Doha, Qatar
2Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar
3Department of Pediatrics, Sidra Medicine, Doha, Qatar
4Ophthalmology Division, Department of Surgery, Sidra Medicine, Doha, Qatar
5Weill Cornell Medicine – Qatar
Idiopathic intracranial hypertension (IIH) is a condition characterized by raised intracranial pressure (ICP) with no evidence of brain pathology, also known as pseudo tumor cerebri. Headache and visual obscuration are the most common presenting symptoms for IIH with a frequency of (68-84%) respectively. Other symptoms of IIH include neck pain, back pain, and radicular pain in the arms and legs resulting from increased spinal pressure and forced filling of the spinal nerves with CSF.
Case summary: We present an 11-year-old boy known to have chronic kidney disease stage II, due to obstructive uropathy. He had a history of Idiopathic intracranial hypertension that was treated completely and condition resolved, then presented with generalized pains and aches without headaches or visual symptoms and found to have IIH for the second time, the symptoms resolved with appropriate treatment.
Conclusion: Widespread pain and several other characteristics of IIH share similarities with characteristics of fibromyalgia (FM) and chronic fatigue syndrome (CFS), two overlapping chronic pain conditions.
Keywords: Idiopathic intracranial hypertension; Fibromyalgia; Papilledema
How to cite this article:
Sondos Altaraqji, Rayan S. Terkawi, Abdallah Alneirab, Diyaa Rachdan, Khalid Mohamed. Fibromyalgia as A Sole First Presentation of Recurring Idiopathic Intracranial Hypertension in a child. A Case Report and Literature Review. International Journal of Case Reports, 2021; 5:205. DOI: 10.28933/ijcr-2021-03-0306
1. Burkett JG, Ailani J. An Up to Date Review of Pseudotumor Cerebri Syndrome. Vol. 18, Cur- rent Neurology and Neuroscience Reports. Current Medicine Group LLC 1; 2018.
2. Cleves-Bayon C. Idiopathic Intracranial Hyper- tension in Children and Adolescents: An Update. Headache. 2018 Mar 1;58(3):485–93.
3. Baykan B, Ekizoǧlu E, Altiokka Uzun G. An update on the pathophysiology of Idiopathic intracranial hypertension alias pseudotumor cerebri. Agri. 2015 Apr 1;27(2):63–72.
4. Libien J, Kupersmith MJ, Blaner W, McDermott MP, Gao S, Liu Y, et al. Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial. J Neurol Sci. 2017 Jan 15;372:78–84.
5. Subramaniam S, Fletcher WA. Obesity and Weight Loss in Idiopathic Intracranial Hyper- tension: A Narrative Review. Vol. 37, Journal of Neuro-Ophthalmology. Lippincott Williams and Wilkins; 2017. p. 197–205.
6. Portelli M, Papageorgiou PN. An update on idiopathic intracranial hypertension. Acta Neu- rochir (Wien). 2017 Mar 1;159(3):491–9.
7. Sinclair AJ, Ball AK, Burdon MA, Clarke CE, Stewart PM, Curnow SJ, et al. Exploring the pathogenesis of IIH: An inflammatory pers- pective. J Neuroimmunol. 2008 Sep 15;201–202(C):212–20.
8. Markey KA, Uldall M, Botfield H, Cato LD, Miah MAL, Hassan-Smith G, et al. Idiopathic intra- cranial hypertension, hormones, and 11β-hydro- xysteroid dehydrogenases. J Pain Res. 2016 Apr 19;9:223–32.
9. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neuro- logy. 2002 Nov 26;59(10):1492–5.
10. Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et al. The idiopathic intracranial hypertension treatment trial clinical profile at baseline. JAMA Neurol. 2014;71(6): 693–701.
11. Hulens M, Bruyninckx F, Rasschaert R, Vansant G, De Mulder P, Stalmans I, et al. Electrodi- agnostic Abnormalities Associated with Fibro- myalgia. J Pain Res. 2020;13:737–44.
12. Hulens M, Rasschaert R, Vansant G, Stalmans I, Bruyninckx F, Dankaerts W. The link between idiopathic intracranial hypertension, fibromyalgia, and chronic fatigue syndrome: exploration of a shared pathophysiology. J Pain Res. 2018;11: 3129–40.
13. Higgins JNP, Pickard JD, Lever AML. Chronic fatigue syndrome and idiopathic intracranial hypertension: Different manifestations of the same disorder of intracranial pressure? Med Hypotheses. 2017;105:6–9.
14. Hulens M, Dankaerts W, Stalmans I, Somers A, Vansant G, Rasschaert R, et al. Fibromyalgia and unexplained widespread pain: The idiopa- thic cerebrospinal pressure dysregulation hypothesis. Med Hypotheses. 2018 Jan;110 (Dece- mber 2017):150–4.
15. Hulens M, Rasschaert R, Dankaerts W, Stal- mans I, Vansant G, Bruyninckx F. Spinal fluid evacuation may provide temporary relief for patients with unexplained widespread pain and fibromyalgia. Med Hypotheses. 2018 Sep;118 (April):55–8.
16. Distelmaier F, Sengler U, Messing-Juenger M, Assmann B, Mayatepek E, Rosenbaum T. Pseudotumor cerebri as an important differential diagnosis of papilledema in children. Brain Dev. 2006 Apr;28(3):190–5.
17. Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Häuser W, Katz RL, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319–29.